Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

  • Scientific challenges facing the TB vaccine field
  • Next Generation TB Vaccines and Vaccine Concepts
  • TB vaccine development

Related Conference of Tuberculosis Vaccines

October 18-19, 2023

43rd Global Summit and Expo on Vaccines & Immunology

Vienna, Austria
November 04-05, 2023

35th Annual Congress on Vaccine and Clinical Trials

Toronto, Canada
November 06-07, 2023

5th World Congress on Vaccine and Immunology

Tokyo, Japan
February 08-09, 2024

4th International Conference on Vaccine Research

Madrid, Spain

Tuberculosis Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in